Navigation Links
UCLA receives $12.5M to lead international project to study proteins implicated in heart disease
Date:9/30/2010

UCLA has received a five-year, $12.5 million contract award from the National Heart, Lung and Blood Institute to spearhead an international consortium of medical experts that will study proteins that may be involved in the development of cardiovascular disease.

Heart disease is a leading killer worldwide, but little is known about cardiac function at the molecular level or how the inner sub-units of a cardiac cell work together as an integrated system. More research in this area, including studying the proteins that trigger all cell activity and functions, may help researchers better understand how proteins can malfunction or cause disease.

Proteomics, the study of the entire set of proteins expressed by the genome, is the next stage of biological research, which builds on the established work of the Human Genome Project. Focusing on the proteins involved in cardiac cells may offer new insights into the development of atherosclerosis and heart failure.

Researchers will also aim to better understand the function of two cardiac cell components that appear to be instrumental in the development of heart disease when they malfunction: mitochondria, the "powerhouses" that provide energy for all cell functions, and proteasomes, which are cell workers that rid the cell of unneeded or damaged proteins. An accumulation of unwanted proteins caused by defects in these two cell sub-units may contribute to heart disease.

"In one of the first efforts of its kind, country borders disappeared as we assembled the very best scientists and physicians from the global community to study the proteome biology of cardiovascular medicine," said Peipei Ping, Ph.D., program director of the National Institutes of Health/National Heart, Lung and Blood Institute Proteomics Project and a professor of physiology, medicine and cardiology at the David Geffen School of Medicine at UCLA.

The international consortium includes leading scientists
'/>"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California -- Los Angeles
Source:Eurekalert

Page: 1 2

Related biology news :

1. Einstein receives $30 million to study protein form and function
2. Prof. Xiaoguang Meng receives honorary master of engineering from Stevens
3. LSU receives $15 million grant from NIH to build biomedical research pipeline for Louisiana
4. Wiecha receives grant to study face-to-face vs. virtual health education for African-American women
5. Georgia State receives $6.7 million grant for research center in health disparities
6. UCSF receives $15.4 million to create systems biology center
7. UofL researcher receives grant from the National Science Foundation
8. USF receives NIH grant to study implications of maternal infection as cause of autism
9. ASU receives 2-year, $5.3 million DARPA award to safeguard soldiers from infectious diseases
10. U of I receives $1 million USDA grant to study Glossy15 in sorghum
11. UCSF receives $15 million to advance personalized medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 21, 2015  Analyst Report Issued by Small Cap IR. In ... that planet-wide, transactions at merchants on the leading payment cards ... of credit, debit, and prepaid cards reached 6.54 billion.  Eight ... fraudulent card usage in 2012, and credit and debit card ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and ... the addition of the "Global Wearable Technologies ... Growth, Share, Overview, Trends and Forecast 2014-2020" ... Wearable Technologies are smart devices that can be ...
(Date:1/22/2015)... 22, 2015 Infinisource has launched its new NXG series ... The G2 sets a higher standard for collecting attendance and ... solution. With plug-and-play installation, touch screen interface and seamless connection ... robust time collection solution for the small to mid-size employer. ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2Infinisource's NXG series sets new time clock standard 2
... fishing ranges despite doing nothing to defend their territory ... team of researchers led by the University of Leeds ... which can fly hundreds of kilometres on a single ... from neighbouring colonies. The findings, published in the ...
... DUBLIN , June 6, 2013 ... addition of the "DNA Microarray 2013: A Focus ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,DNA Microarray 2013 ... DNA Microarray, involving the participation of 201 buyers and ...
... their enemies in order to kill them. They can,t be ... opponents. But indifference to the enemy, rather than loathing, may ... path back to healthy civilian lives, researchers at Case Western ... work showing how the brain operates when people objectifythat is, ...
Cached Biology News:Gannets don't eat off each other's plates 2Gannets don't eat off each other's plates 3DNA Microarray 2013 Market Report: A Focus on Sales Growth 2A way of thinking may enable battle but prevent war crimes 2A way of thinking may enable battle but prevent war crimes 3A way of thinking may enable battle but prevent war crimes 4A way of thinking may enable battle but prevent war crimes 5A way of thinking may enable battle but prevent war crimes 6
(Date:2/26/2015)... Los Angeles, CA (PRWEB) February 26, 2015 ... organizing an online demonstration to support life extension technologies ... to 8pm UTC, Universal Coordinated Time, on March 21st ... around the world. , Eric Schulke, Founder of ... we must act with urgency. The Movement for Indefinite ...
(Date:2/26/2015)... BioEnterprise today announced that Northeast Ohio ... in growth funding during the past 13 years.  Funding ... – including the Ohio Third Frontier - and federal ... raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... February 26, 2015 RURO, Inc., a ... FreezerPro® version 6.2 – the latest update to the ... is that of a quick and easy method to ... the latest version, RURO engineering has enhanced the system’s ... move large amounts of sample records. , "FreezerPro ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015 ... Gold Partner status in Oracle PartnerNetwork. In attaining Gold ... its commitment to establish Oracle-related knowledge in delivering Ceres, ... challenges of joint customers. Originally developed for ... to rapidly zoom in and out of massive amounts ...
Breaking Biology Technology:Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4RURO Releases FreezerPro® version 6.2 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 4
... Champions,Biotechnology, Inc. (OTC Bulletin Board: CSBR), a ... and tumor specific data to,enhance the value of ... private financing. Under the terms of the private ... Company,s,common stock at $1.75 per share. There were ...
... Science,Corporation (Nasdaq: CSCX ), a global leader ... announced today,that it will release its first quarter ... the market close. The Company has scheduled a,conference ... Eastern Time to,discuss the financial results for the ...
... treating individuals with cancer would find a noninvasive method to ... because low levels of oxygen in a tumor have been ... this and to image the surrounding organs and tissues at ... tumors in mice by Murali Krishna and colleagues, at the ...
Cached Biology Technology:Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share 2Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share 3Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 2
... targets including proteins and to their modification ... antigens. A&Gs service is divided into ... 40 days (duration may vary slightly dependent ... I: Immunization, test bleed and fusion; $2,500 ...
... Clone/PAD: ZMD.368. Immunogen: Synthetic peptide ... the human WNT2B/WNT13 protein. Specificity: ... mouse and rat WNT2B/WNT13 proteins. Recognizes ... Reactivity: Mouse Human Rat (positive ...
... Immunogen: Synthetic peptide derived from ... protein (chromosome 17 open reading frame 37 ... for the C35 protein. On Western blots ... kDa band. Reactivity: Human (positive control: ...
...
Biology Products: